Hinchcliffe M - Search Results

1

Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis.

Pearson RG, Masud T, Blackshaw E, Naylor A, Hinchcliffe M, Jeffery K, Jordan F, Shabir-Ahmed A, King G, Lewis AL, Illum L, Perkins AC. Pearson RG, et al. Among authors: hinchcliffe m. Pharmaceutics. 2019 Jun 7;11(6):265. doi: 10.3390/pharmaceutics11060265. Pharmaceutics. 2019. PMID: 31181662 Free PMC article.

2

Clearance characteristics of chitosan based formulations in the sheep nasal cavity.

Soane RJ, Hinchcliffe M, Davis SS, Illum L. Soane RJ, et al. Among authors: hinchcliffe m. Int J Pharm. 2001 Apr 17;217(1-2):183-91. doi: 10.1016/s0378-5173(01)00602-0. Int J Pharm. 2001. PMID: 11292554

3

Gastrointestinal transit of dosage forms in the pig.

Davis SS, Illum L, Hinchcliffe M. Davis SS, et al. Among authors: hinchcliffe m. J Pharm Pharmacol. 2001 Jan;53(1):33-9. doi: 10.1211/0022357011775163. J Pharm Pharmacol. 2001. PMID: 11206190

4

The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model.

Illum L, Hinchcliffe M, Davis SS. Illum L, et al. Among authors: hinchcliffe m. Pharm Res. 2003 Sep;20(9):1474-84. doi: 10.1023/a:1025722614154. Pharm Res. 2003. PMID: 14567644

5

Intranasal insulin delivery and therapy.

Hinchcliffe M, Illum L. Hinchcliffe M, et al. Adv Drug Deliv Rev. 1999 Feb 1;35(2-3):199-234. doi: 10.1016/s0169-409x(98)00073-8. Adv Drug Deliv Rev. 1999. PMID: 10837698

6

Chitosan as a novel nasal delivery system for vaccines.

Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher AN, Davis SS. Illum L, et al. Among authors: hinchcliffe m. Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):81-96. doi: 10.1016/s0169-409x(01)00171-5. Adv Drug Deliv Rev. 2001. PMID: 11516781 Review.

7

Distribution of Droplets and Immune Responses After Aerosol and Intra-Nasal Delivery of Influenza Virus to the Respiratory Tract of Pigs.

Martini V, Hinchcliffe M, Blackshaw E, Joyce M, McNee A, Beverley P, Townsend A, MacLoughlin R, Tchilian E. Martini V, et al. Among authors: hinchcliffe m. Front Immunol. 2020 Oct 27;11:594470. doi: 10.3389/fimmu.2020.594470. eCollection 2020. Front Immunol. 2020. PMID: 33193445 Free PMC article.

8

Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation.

Cheng YH, Watts P, Hinchcliffe M, Hotchkiss R, Nankervis R, Faraj NF, Smith A, Davis SS, Illum L. Cheng YH, et al. Among authors: hinchcliffe m. J Control Release. 2002 Feb 19;79(1-3):243-54. doi: 10.1016/s0168-3659(01)00553-3. J Control Release. 2002. PMID: 11853935

9

Intranasal delivery of morphine.

Illum L, Watts P, Fisher AN, Hinchcliffe M, Norbury H, Jabbal-Gill I, Nankervis R, Davis SS. Illum L, et al. Among authors: hinchcliffe m. J Pharmacol Exp Ther. 2002 Apr;301(1):391-400. doi: 10.1124/jpet.301.1.391. J Pharmacol Exp Ther. 2002. PMID: 11907197 Clinical Trial.

10

Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.

Dyer AM, Hinchcliffe M, Watts P, Castile J, Jabbal-Gill I, Nankervis R, Smith A, Illum L. Dyer AM, et al. Among authors: hinchcliffe m. Pharm Res. 2002 Jul;19(7):998-1008. doi: 10.1023/a:1016418523014. Pharm Res. 2002. PMID: 12180553

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page